approved EB-1A
AI Review Lead
Mathematical Modeling, Artificial Intelligence, And Precision Medicine · China · 2025-10-14
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 11 peer-reviewed journal articles and 2 preprints in the field of mathematical modeling.
Judging (Met)
The petitioner completed 11 peer reviews, served as an area chair for an international conference, and participated in federal grant reviews.
Original Contributions (Met)
The petitioner developed AI algorithms and frameworks cited by government initiatives and used to accelerate drug development.
Why This Petition Was Approved
The petition was approved based on 11 peer-reviewed articles and 2 preprints with 236 citations, placing several papers in the top 10% of the field. The petitioner satisfied EB-1A criteria through 11 peer reviews for leading journals, serving as an area chair for an international AI conference, and participating in federal grant reviews. His work on AI transparency and reliability was also recognized for its alignment with U.S. government regulatory initiatives.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- 11 peer-reviewed journal articles
- 2 preprints
- 236 citations from researchers in 24 countries
- 11 peer reviews for leading journals
- Area Chair for an international AI conference
- Participation in federal grant reviews
- Development of AI algorithms for personalized medicine
- Computational frameworks referenced in U.S. Government Regulatory initiatives
Similar Cases
Scientist
Pharmaceuticals · India
WeGreened EB-1A approved
Massachusetts 410 days 2025-10-06
The petition was approved based on the petitioner's authorship of 27 peer-reviewed articles and 17 abstracts, which garnered 485 citations from researchers in over 40 countries. His work ranked in the top 10% of most-cited publications in pharmacology for several years. Additionally, he completed over 60 peer reviews and received research grants from the NIH and the National Research Foundation of South Korea.
Scientist
Pharmaceuticals · China
WeGreened EB-1A approved
Massachusetts 21 days 2025-05-29
The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.
Others
Biotechnology · United Kingdom
WeGreened EB-1A approved
20 days 2025-12-09
The petition was approved based on the satisfaction of at least three EB-1A criteria, including scholarly articles, judging, and original contributions of major significance. Specific metrics included 8 peer-reviewed journal articles, 904 citations, and 15 peer review assignments for influential AI and computational venues. The case was strengthened by evidence of competitive funding from the Bill & Melinda Gates Foundation and Roche GmbH.
Others
Biotechnology · China
WeGreened EB-1A approved
Pennsylvania 59 days 2025-01-24
The petitioner submitted evidence of 20 peer-reviewed publications and 1,642 citations, placing him in the top 1% of his field. He also demonstrated his authority through 17 peer review invitations and research funding from the NSF, NIGMS, and DTRA. The case was approved after a successful NOID response emphasizing the broad implementation of his AI models and their impact on a startup that secured $27 million in financing.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-14.
Browse all casesAt a Glance
Outcome approved
Processing 207 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist